Do You Actually Need 10,000 Steps a Day?

No, and the number never came from research. A meta-analysis of 15 international cohorts covering 47,471 adults found the risk of death levelled off at roughly 8,000 to 10,000 steps a day for people under 60, and 6,000 to 8,000 for those over 60. A 2025 systematic review found that compared with 2,000 steps a day, 7,000 steps was associated with a 47 per cent lower risk of all-cause mortality.

So most of the available benefit arrives well before you get there, and the target itself has a different origin from the evidence.

What the evidence shows

The 2022 meta-analysis in The Lancet Public Health, by Paluch and colleagues on behalf of the Steps for Health Collaborative, opens by stating the problem: although 10,000 steps per day is widely promoted to have health benefits, there is little evidence to support this recommendation.

They pooled 15 studies, seven published and eight unpublished, covering 47,471 adults with 3,013 deaths over a median follow-up of 7.1 years. Participants were grouped into quartiles by average daily steps: 3,553 in the lowest, then 5,801, then 7,842, then 10,901.

Compared with the lowest quartile, the adjusted hazard ratio for all-cause mortality was 0.60 for the second quartile, 0.55 for the third, and 0.47 for the fourth.

Look at where the change happens. Moving from about 3,500 to about 5,800 steps produced most of the drop. Going from 7,800 to 10,900 moved the hazard ratio from 0.55 to 0.47.

The spline analysis makes it explicit: risk decreased progressively until 6,000 to 8,000 steps a day in adults aged 60 and over, and until 8,000 to 10,000 steps in adults under 60.

The 2025 update

A more recent systematic review and dose-response meta-analysis in the same journal extended this across many more outcomes.

Compared with 2,000 steps a day, 7,000 steps was associated with a 47 per cent lower risk of all-cause mortality across 14 studies, a 25 per cent lower risk of cardiovascular disease incidence, a 47 per cent lower risk of cardiovascular disease mortality, a 37 per cent lower risk of cancer mortality, a 14 per cent lower risk of type 2 diabetes, a 38 per cent lower risk of dementia, a 22 per cent lower risk of depressive symptoms, and a 28 per cent lower risk of falls.

Cancer incidence was the exception, with a non-significant 6 per cent lower risk.

Note the comparator. These figures compare 7,000 steps against 2,000, which is the difference between a mostly sedentary day and a moderately active one. That is the gap where the numbers live.

The depressive symptoms finding is worth reading alongside exercise as a treatment for depression, where randomised trials rather than cohorts produce a considerably stronger claim.

Where the target came from

The 2022 authors say plainly that there is little evidence supporting the 10,000 figure. The commonly repeated account of its origin, described in the university announcement of that study, is that the mantra grew out of a decades-old marketing campaign for a Japanese pedometer, with no science behind its impact on health.

That is worth knowing not because marketing origins make a number wrong, but because it explains why the research had to be done afterwards to find out whether it happened to be right. It turned out to sit at the top of the range where benefit has already levelled off for younger adults, and above it for older ones.

What this is and is not

Everything here is observational. These are cohort studies of people who happened to walk more or less, pooled and adjusted, not trials that assigned people to step counts.

The 2022 analysis adjusted for age, accelerometer wear time, race and ethnicity, sex, education or income, body mass index, and study-specific lifestyle and chronic condition variables. That is careful work and it does not eliminate the possibility that healthier people walk more rather than walking making people healthier.

The authors’ own framing is appropriately cautious: taking more steps per day was associated with a progressively lower risk of all-cause mortality, up to a level that varied by age, and the findings can be used to inform step guidelines.

Associated with, and can inform. Not causes, and not prescribes.

What this means if you sit for a living

The practical shape is more encouraging than the target ever was.

If you are currently in the range of a mostly desk-bound day, the largest measured differences are between very low and moderate step counts, not between moderate and high. The second quartile in the 2022 analysis, averaging under 6,000 steps, already showed a hazard ratio of 0.60 against the lowest.

That reframes the problem from hitting a demanding target to moving out of the bottom group, which is a smaller ask and where the evidence says most of the difference sits. It is a different question from how often to get up from sitting or from standing desks, both of which concern breaking up sitting rather than accumulating volume.

If you have a heart or lung condition, joint problems, or have been inactive for a long time, increasing activity is worth discussing with a doctor first, particularly regarding pace and progression. If you become breathless or get chest pain on exertion that you did not have before, that is a reason to stop and be seen rather than to push through.

Common questions

Is 10,000 steps a made-up number?

It did not come from research. The 2022 Lancet Public Health meta-analysis opens by noting that although 10,000 steps per day is widely promoted to have health benefits, there is little evidence to support this recommendation. The commonly reported origin, as described in the university announcement of that study, is a decades-old marketing campaign for a Japanese pedometer, with no science backing its health impact. What the research since has found is that mortality risk decreased progressively until 6,000 to 8,000 steps a day in adults 60 and over, and until 8,000 to 10,000 steps in adults under 60. So 10,000 sits at or above where the benefit levels off, depending on your age.

How many steps should I aim for?

The evidence points lower than the popular target and varies by age, and this article gives no personal prescription. The 2022 meta-analysis found mortality risk plateaued at approximately 6,000 to 8,000 steps for adults aged 60 and older and 8,000 to 10,000 for adults under 60. A 2025 dose-response meta-analysis found that compared with 2,000 steps a day, 7,000 steps was associated with a 47 per cent lower risk of all-cause mortality, along with lower risks of cardiovascular disease, cancer mortality, type 2 diabetes, dementia, depressive symptoms and falls. All of this is observational. If you have a heart or lung condition or joint problems, discuss increasing activity with a doctor.

Does it matter how fast I walk?

The evidence on pace is weaker than the evidence on volume. In the 2022 meta-analysis, after adjusting for the number of steps per day, the association between higher stepping rates and mortality was attenuated but remained significant for peak 30-minute and peak 60-minute cadence, with hazard ratios of 0.67 for both. It was not significant for time spent walking at 40 steps per minute or faster, or at 100 steps per minute or faster. So some cadence measures held up after adjustment and others did not, which is a mixed picture rather than a case for walking faster.

Is walking more actually causing the benefit?

That has not been established, and the studies were not designed to. All the findings here come from cohort studies of people who happened to walk more or less, not from trials assigning people to step counts. The 2022 analysis adjusted for age, wear time, race and ethnicity, sex, education or income, body mass index and study-specific lifestyle and chronic condition variables, which is careful, and does not rule out healthier people simply walking more. The authors describe their findings as associations that can be used to inform step guidelines, which is the appropriately cautious framing.

Aim at the bottom of the range, not the top

What makes this literature useful is not that it lowers the target. It is that it shows the target was pointed at the wrong end of the curve.

The steepest part of the association is between very low step counts and moderate ones. In the 2022 pooled data, moving from an average of around 3,500 steps to around 5,800 was where most of the difference in hazard ratio appeared. The stretch from 7,800 to 10,900, the part that requires deliberate effort and a tracking app and a certain amount of self-negotiation in the evening, moved the number considerably less.

For anyone whose job is sitting at a screen, that is the more relevant fact by some distance. The question was never whether you can reach a target invented to sell pedometers. It is whether you spend most days in the lowest group, and the evidence says that is where the difference is.